Looking for information about Informa TechTarget products and services? The commercial homepage has moved. Visit Informa TechTarget News 25 Jul 2025 / Pharmaceuticals FDA regulatory gaps fuel unsafe compounded GLP-1 drugs Regulatory loopholes let compounders mass-produce untested GLP-1 drug knock-offs under the guise of personalization, prompting urgent FDA action to ensure patient safety. 24 Jul
